Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 10.10 Celularity Inc. [2017 Equity Incentive Plan]
- 10.11 Form of Celularity Stock Option Grant Notice, Option Agreement and Notice of Exercise Under the 2017 Equity Incentive Plan
- 10.14 Celularity Inc. Annual Incentive Plan
- 10.15 Employment Agreement by and Between Celularity and Robert J. Hariri, Dated As of January 7, 2021
- 10.16 Employment Agreement by and Between Celularity and David C. Beers, Dated As of January 7, 2021
- 10.17 Employment Agreement by and Between Celularity and Gregory Berk, Dated As of January 7, 2021
- 10.18 Employment Agreement by and Between Celularity and Stephen A. Brigido, Dated As of January 7, 2021
- 10.19 Employment Agreement by and Between Celularity and Keary Dunn, Dated As of January 7, 2021
- 10.20 Employment Agreement by and Between Celularity and John R. Haines, Dated As of January 7, 2021
- 10.21 Employment Agreement by and Between Celularity and Xiaokui Zhang, Dated As of January 7, 2021
- 10.27 Warrant to Purchase Series B Preferred Stock of Celularity Inc., by and Between Celularity Inc. and Dragasac Limited, Dated January 9, 2020
- 10.28 Form of Warrant to Purchase Series B Preferred Stock of Celularity Inc., Dated March 16, 2020
- 10.29 Form of Amendment NO.1 to Warrant to Purchase Series B Preferred Stock of Celularity Inc., Dated As of January 8, 2021 by and Between Celularity Inc. and [the Starr Group] C.V. Starr & Co., Inc.
- 10.30 Amendment NO.1 to Warrant to Purchase Series B Preferred Stock of Celularity Inc., Dated As of March 16, 2020 by and Between Celularity Inc. and Dragasac Limited
- 10.31 Amendment NO.2 to Warrant to Purchase Series B Preferred Stock of Celularity Inc., Dated As of January 8, 2021 by and Between Celularity Inc. and Dragasac Limited
- 10.32 Lease Agreement, Dated March 13, 2019, by and Between LSREF4 Turtle, LLC and Celularity Inc.
- 23.1 Consent of Independent Registered Public Accounting Firm of GX Acquisition Corp
- 23.2 Consent of Independent Registered Public Accounting Firm of Celularity Inc
- 99.2 Consent of Robert J. Hariri to Be Named As a Director
- 99.3 Consent of John Sculley to Be Named As a Director
- 99.4 Consent of Peter Diamandis to Be Named As a Director
- 99.5 Consent of Lim Kok Thay to Be Named As a Director
- 99.6 Consent of Robin L. Smith to Be Named As a Director
- 99.7 Consent of Andrew C. Von Eschenbach to Be Named As a Director
Associated filings
- 28 Jun 21 EFFECT Notice of effectiveness
- 25 Jun 21 424B3 Prospectus supplement
- 22 Jun 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 7 Jun 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 23 Apr 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 29 Mar 21 S-4/A Registration of securities issued in business combination transactions (amended)
-
25 Jan 21 S-4 Registration of securities issued in business combination transactions
CELU similar filings
- 7 Jun 21 Registration of securities issued in business combination transactions (amended)
- 23 Apr 21 Registration of securities issued in business combination transactions (amended)
- 29 Mar 21 Registration of securities issued in business combination transactions (amended)
- 25 Jan 21 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Registration Statement of GX Acquisition Corp. on Form S-4 of our report dated March 23, 2020 with respect to our audits of the financial statements of GX Acquisition Corp. as of December 31, 2019 and 2018, for the year ended December 31, 2019 and for the period from August 24, 2018 (inception) through December 31, 2018, which report appears in the proxy statement/prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such proxy statement/prospectus.
/s/ Marcum llp
Marcum llp
New York, NY
January 25, 2021